Harvard Researchers’ Immune-Silent Stem Cell Technology Licensed to Sana Biotechnology
Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease CAMBRIDGE, Mass.–(BUSINESS WIRE)–Protecting transplanted…